COMPOZIŢII FARMACEUTICE CUPRINZÂND SULFONAMIDE CE CONŢIN THF ŞI UTILIZAREA ACESTORA CA INHIBITORI AI ASPARTIL PROTEAZEI
Price not visible for this package
Interest:
Assignment
Publication info:
No.: RO119302
Date: 30.07.2004
Inventor(s):
TUNG ROGER D [US]
Applicant(s):
VERTEX PHARMA [US]
Classification:
International patent classification (IPC):
A61K31/335; A61K31/34; A61K31/341; A61K31/343; A61K31/36; A61K31/38; A61K31/381; A61K31/40; A61K31/4025; A61K31/41; A61K31/4155; A61K31/42; A61K31/422; A61K31/425; A61K31/427; A61K31/44; A61K31/4427; A61K31/443; A61K31/4433; A61K31/445; A61K31/535; A61P31/12; A61P31/18; A61P43/00; C07D207/26; C07D209/08; C07D213/30; C07D215/48; C07D231/14; C07D239/22; C07D263/24; C07D271/08; C07D277/36; C07D307/12; C07D307/14; C07D307/20; C07D307/52; C07D307/64; C07D307/79; C07D403/12; C07D405/12; C07D407/12; C07D409/12; C07D409/14; C07D413/12; C07D413/14; C07D417/12; C07D521/00; C07K5/078; A61K38/00
Cooperative patent classification (CPC):
A61P31/12 (EP); A61P31/18 (EP); A61P43/00 (EP); C07D207/26 (EP, KR, US); C07D209/08 (EP, US); C07D213/30 (EP, US); C07D215/48 (EP, KR, US); C07D231/12 (EP, US); C07D231/14 (EP, KR, US); C07D233/56 (EP, US); C07D239/22 (EP, KR, US); C07D249/08 (EP, US); C07D263/24 (EP, KR, US); C07D271/08 (EP, KR, US); C07D277/36 (EP, KR, US); C07D307/12 (EP, KR, US); C07D307/20 (EP, KR, US); C07D403/12 (EP, KR, US); C07D405/12 (EP, KR, US); C07D409/12 (EP, US); C07D409/14 (EP, US); C07D413/12 (EP, US); C07D413/14 (EP, US); C07D417/12 (EP, US); C07K5/06139 (EP, US); A61K38/00 (EP, US)
Application info:
No.: RO19970001926
Date:
18.04.1996
Priority number(s):
US19950424819
19.04.1995
; WO1996US05475
18.04.1996
Related patents:
AP950; ATE222761; AU5559696; AU706732; BG102048; BG63677; BR9608032; CA2217737; CN1181755; CY2317; CZ291054; CZ329397; DE69623298; DK0846110; EA001221; EA199700331; EE04307; EE9700266; EP0846110; ES2181882; GEP20012415; HU224027; HU9801877; IS2155; IS4574; JP3046357; JPH10509739; KR19990007824; NO317734; NO974722; NZ306903; PL195368; PL322877; PT846110; SK143197; SK284785; TR199701199; UA54392; US5723490; WO9633184
Description:
Prezenta invenţie se referă la compoziţii farmaceutice cuprinzând sulfonamide ce conţin THF, precum şi la utilizarea acestora ca inhibitori ai activităţii proteazei HIV-1 şi HIV-2 şi de aceea, se pot utiliza ca agenţi antivirali împotriva virusurilor HIV-1 şi HIV-2. ŕ